by Jen Hodson | Jan 29, 2020 | Press Releases
Derived from deep-learning models, the findings demonstrate novel AI methods of identifying tumor-infiltrating lymphocytes (TILs) in lung cancers Burlingame, CA – January 28, 2020: NantHealth, Inc. (NASDAQ: NH), a next-generation, evidence-based, personalized...
